Recent years have witnessed significant advancements in the medical application of cannabis and cannabinoids. Mainly, it is driven by evolving legislation and a deeper understanding of their therapeutic potential.
Regulatory Developments
In 2024, the U.S. Congress advanced legislation aimed at changing the regulation of hemp-derived products, reflecting a growing recognition of cannabis’s medical potential.
Research Initiatives
The Cannabis Clinical Outcomes Research Conference (CCORC) 2024 focused on increasing stakeholder engagement with research, underscoring the growing interest in understanding how cannabis and cannabinoids can be harnessed for medical purposes.
Therapeutic Applications
Recent studies have explored the efficacy of cannabis in treating various conditions. Cannabis and cannabinoids are being used to manage various health conditions, with pain, sleep disorders, anxiety, and depression being the most common.
♦ Interested in high-quality CBD edibles and merchandise? Check out the FGE shop ♦
A British biotech company developed a cannabis-mimicking drug designed to help cancer-related cachexia patients regain weight and muscle lost due to the disease and its treatment. This drug leverages the appetite-stimulating effects of cannabis without inducing a high, aiming to improve patients’ quality of life.
Public Health Perspectives
The Centers for Disease Control and Prevention (CDC) has outlined a vision for fiscal years 2020-2025 to address emerging public health issues related to cannabis use, emphasizing the need for a health-focused strategy in U.S. cannabis policy.
Conclusion
The period of 2024-2025 marks a transformative era in the medical use of cannabis and cannabinoids. Regulatory changes, coupled with ongoing research, are expanding the therapeutic applications of these compounds. As scientific understanding deepens, cannabis-based treatments are poised to play an increasingly prominent role in modern medicine.
